Infinium Pharmachem Ltd
Ticker: INFINIUM
Decent
63/100
☆ Add to Watchlist
Investing Reference
Price
252.00
Market Cap
392.69
Debt/Equity
0.4155
ROE %
8.810
PB
3.1468
Promoter %
65.238
Pledge %
0.000
1Y Rev Growth %
15.036
5Y Rev Growth %
31.983
NP Margin %
5.164
NP Margin 5Y Avg %
6.306
Trading Reference
1M Return %
-3.260
6M Return %
5.219
1Y Return %
-24.911
% Away 52W High
38.889
% Away 52W Low
17.812
Daily Volume
2000
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
L
Logica Infoway Ltd
Logica Infoway Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Naga Dhunseri Group Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
B
Bombay Oxygen Investments Ltd
The stock presents several risks with limited growth prospects and inconsistent performance metrics, making it a risky investment.
View details
H
Harrisons Malayalam Ltd
Harrisons Malayalam Ltd shows potential but is hindered by inconsistent growth and profitability, along with governance concerns.
View details
S
SKP Bearing Industries Ltd
SKP Bearing Industries Ltd shows potential for moderate growth but faces challenges in profitability and valuation metrics.
View details
I
International Travel House Ltd
The stock presents several risks with moderate growth potential, making it a risky investment at this time.
View details
S
Shivam Autotech Ltd
Shivam Autotech Ltd shows potential in a growing sector but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
T
Twamev Construction and Infrastructure Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
P
Prime Fresh Ltd
Prime Fresh Ltd shows potential in a growing sector, but faces challenges in consistency and governance, warranting cautious consideration.
View details
S
Shalibhadra Finance Ltd
Shalibhadra Finance Ltd shows several weaknesses in growth, profitability, and governance, making it a risky investment.
View details
F
Frog Cellsat Ltd
Frog Cellsat Ltd presents several risks with inconsistent growth and valuation concerns, making it a risky investment at this time.
View details
A
Aelea Commodities Ltd
Aelea Commodities Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
DC Infotech and Communication Ltd
DC Infotech and Communication Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
A
Aerpace Industries Ltd
Aerpac Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Inspirisys Solutions Ltd
Inspirisys Solutions Ltd presents several risks, particularly in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
P
Phoenix Township Ltd
Phoenix Township Ltd shows some potential but faces significant challenges in profitability and market perception.
View details
Business Overview
Infinium Pharmachem Ltd is a leading player in the pharmaceutical and chemical sectors, specializing in high-quality active pharmaceutical ingredients (APIs) and intermediates. Catering primarily to the Indian market, the company is dedicated to enhancing healthcare solutions with its innovative products. Infinium's commitment to quality and compliance with international standards makes it a trusted partner for pharmaceutical companies. Its strategic focus on research and development ensures a robust pipeline of cutting-edge solutions, positioning it as a key contributor to the growth of the Indian pharmaceutical landscape.
- Leading manufacturer of APIs and intermediates
- Focus on quality and international compliance
- Strong commitment to research and development
- Supports the growth of the Indian pharmaceutical sector
- Trusted partner for healthcare solutions
Investment Thesis
Infinium Pharmachem Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This positions the company well for sustained growth, making it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services sector.
- Attractive valuation metrics compared to industry peers.
- Focus on innovation and quality positions the company favorably.
- Robust financials and growth strategy support long-term value creation.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Strong R&D pipeline
- Expansion into international markets
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory changes affecting operations
- High competition in the sector
- Dependence on key suppliers
- Market volatility impacting stock price
Peer Perspective
Infinium Pharmachem Ltd trades at a discount to peers like Aarti Industries and Alkyl Amines in terms of valuation. A sustained improvement in margins and consistent growth could trigger a rerating in its stock price.
Future Outlook
Infinium Pharmachem Ltd is well-positioned for growth, driven by innovative product development and expanding market reach. Successful execution of its strategic initiatives and effective cost control will be key to unlocking its full potential.
📊 Stock Investment Checklist (100 Points)
Infinium Pharmachem Ltd • Updated: 2025-09-17 15:46:48
-
10BusinessHighPharmaceutical sector shows growth potential, but competition is high.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
5GovernanceGoodPromoter holding is strong, but there are some concerns about pledging.
-
5DriversGoodGrowth catalysts exist, but execution risks are significant.
-
3TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 63 / 100
• Decent
Infinium Pharmachem Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100